Report: Pfizer making $100 billion play for Astra Zeneca

LONDON — Pfizer is making a bid of $100.8 billion (£60 billion) for Astra Zeneca, according to a report in the Sunday Times, a U.K. daily, published Sunday. 

Citing insiders, the Sunday Times reported that, internally, Astra Zeneca is resisting the overture. 

"The New York company is keen to deploy a $70 billion (£42 billion) cash pile that it has accumulated in overseas subsidiaries," the paper reported.